Research graph
References from Dietary oat β-glucan attenuates TNBS-induced colitis-associated hepatic redox and inflammatory disturbances via the gut-liver axis. Local targets link to admitted publications; unresolved targets remain external evidence.
Global evolution of inflammatory bowel disease across epidemiologic stages
2025 · External reference
Hepatobiliary manifestations and complications in inflammatory bowel disease: a review
10.14740/gr990w · 2018 · External reference
Hepatobiliary impairments in patients with inflammatory bowel diseases: the current approach
2023 · External reference
Past, current, and future trends in the prevalence of primary Sclerosing cholangitis and inflammatory bowel disease across England (2015–2027): a Nationwide, population-based study
2024 · External reference
The gut-liver Axis in liver disease: pathophysiological basis for therapy
10.1016/j.jhep.2019.10.003 · 2020 · External reference
Gut-liver Axis: pathophysiological concepts and clinical implications
10.1016/j.cmet.2022.09.017 · 2022 · External reference
Roles of the Inflammasome in the gut-liver Axis
10.1007/s00894-018-3886-2 · 2019 · External reference
Gut bacteria exacerbate TNBS-induced colitis and kidney injury through oxidative stress
10.1016/j.redox.2024.103140 · 2024 · External reference
Immunomodulatory effect and biological significance of β-glucans
10.3390/pharmaceutics15061615 · 2023 · External reference
Immunomodulation of fungal β-glucan in host defense signaling by Dectin-1
10.4062/biomolther.2012.20.5.433 · 2012 · External reference
The effects of β-glucan on human immune and cancer cells
10.1186/1756-8722-2-25 · 2009 · External reference
Structure-functional activity relationship of β-glucans from the perspective of immunomodulation: a mini-review
10.3389/fimmu.2020.00658 · 2020 · External reference
Oat β-glucan reduces colitis by promoting autophagy flux in intestinal epithelial cells via the EPHB6-TFEB axis
10.3389/fphar.2023.1189229 · 2023 · External reference
Anti-inflammatory activity of oat beta-glucans in a Crohn’s disease model: time- and molar mass-dependent effects
10.3390/ijms22094485 · 2021 · External reference
Oat β-glucan alleviates DSS-induced colitis via regulating gut microbiota metabolism in mice
10.1039/d1fo01446c · 2021 · External reference
A critical review on the impacts of β-glucans on gut microbiota and human health
10.1016/j.jnutbio.2018.06.010 · 2018 · External reference
Microbiota modulation by dietary oat Beta-glucan prevents Steatotic liver disease progression
2024 · External reference
Utilization of food-derived β-glucans to prevent and treat non-alcoholic fatty liver disease (NAFLD)
10.3390/foods12173279 · 2023 · External reference
Selected physiological activities and health-promoting properties of cereal Beta-glucans. A review
2017 · External reference
Beneficial effects of oat Beta-glucan dietary supplementation in colitis depend on its molecular weight
10.3390/molecules24193591 · 2019 · External reference
Proteinaceous residue removal from oat β-glucan extracts obtained by alkaline water extraction
10.3390/molecules24091729 · 2019 · External reference
Effect of size reduction by freeze-milling on processing properties of Beta-glucan oat bran
10.1016/j.jcs.2014.10.010 · 2015 · External reference
Time-dependent indirect antioxidative effects of oat Beta-glucans on peripheral blood parameters in the animal model of colon inflammation
10.3390/antiox9050375 · 2020 · External reference
Assay for lipid peroxides in animal tissues by Thiobarbituric acid reaction
10.1016/0003-2697(79)90738-3 · 1979 · External reference
Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?
10.1007/s10620-006-9622-2 · 2007 · External reference
Metabolic dysfunction-associated Steatotic liver disease-induced changes in the antioxidant system: a review
10.1007/s00204-024-03889-x · 2025 · External reference
Oat Beta-glucan as a metabolic regulator in the early stage of colorectal cancer-a model study on Azoxymethane-treated rats
10.3390/ijms25094635 · 2024 · External reference
β-glucan from Saccharomyces cerevisiae alleviates oxidative stress in LPS-stimulated RAW264.7 cells via the Dectin-1/Nrf2/HO-1 signaling pathway
10.1007/s12192-021-01205-5 · 2021 · External reference
Mechanism of action and therapeutic implications of Nrf2/HO-1 in inflammatory bowel disease
10.3390/antiox13081012 · 2024 · External reference
Effects of dietary oat Beta-glucans on colon apoptosis and autophagy through TLRs and Dectin-1 signaling pathways-Crohn’s disease model study
10.3390/nu13020321 · 2021 · External reference
IL-6 in inflammation, autoimmunity and Cancer
10.1093/intimm/dxaa078 · 2021 · External reference
NF-κB in biology and targeted therapy: new insights and translational implications
2024 · External reference
Impact of low and high molecular weight oat Beta-glucan on oxidative stress and antioxidant defense in spleen of rats with LPS-induced enteritis
10.1016/j.foodhyd.2015.05.025 · 2015 · External reference
Preclinical study in vivo for new pharmacological approaches in inflammatory bowel disease: a systematic review of chronic model of TNBS-induced colitis
10.3390/jcm8101574 · 2019 · External reference
